Agenus, Inc.
(NASDAQ : AGEN)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
GILDGilead Sciences, Inc. -0.96%66.921.0%$1038.20m
BIIBBiogen, Inc. 0.79%335.641.5%$704.88m
AMGNAmgen, Inc. -0.97%221.321.3%$583.58m
ILMNIllumina, Inc. -0.15%298.463.5%$439.51m
REGNRegeneron Pharmaceuticals, Inc. -0.50%397.552.6%$385.17m
VRTXVertex Pharmaceuticals, Inc. -0.50%242.611.9%$347.12m
ALXNAlexion Pharmaceuticals, Inc. -0.72%101.822.0%$207.11m
EXASEXACT Sciences Corp. -0.51%97.6824.0%$164.58m
AAgilent Technologies, Inc. -1.21%84.781.6%$149.55m
SGENSeattle Genetics, Inc. 1.62%119.986.1%$118.13m
MRNAModerna, Inc. -1.26%18.760.0%$109.88m
INCYIncyte Corp. 0.01%78.462.5%$101.23m
XLRNAcceleron Pharma, Inc. 0.22%93.876.1%$100.00m
SRPTSarepta Therapeutics, Inc. -1.79%123.1714.6%$95.49m
BMRNBioMarin Pharmaceutical, Inc. -0.64%88.444.3%$93.36m

Company Profile

Agenus, Inc. is a clinical-stage immuno-oncology company, which engages in the development and commercialization of technologies to treat cancers and infectious diseases. Its product pipeline includes AGEN1884, AGEN2034, INCAGN1876, INCAGN1949, Prophage, AutoSynVax, PhosphoSynVax, and AS-21 Stimulon. The company was founded by Garo H. Armen and Pramod K. Srivastava in March 1994 and is headquartered in Lexington, MA.